Lisdexamfetamine, marketed as Vyvanse, is a scheduled medication approved for attention deficit hyperactivity disorder in children and adults . In Canada, its distribution is strictly regulated by Health https://teva-lisdexamfetamine-fo198108.life3dblog.com/41472802/vyvanse-in-canada-a-complete-guide